5-year relative survival in early- (age 20-49 years) and later-onset (age 50-84 years) esophagogastric adenocarcinoma diagnosed in years 2007-2019 together with early-to-later-onset excess mortality rate ratios (EMRR) with 95% confidence intervals (CI).
No takes yet. Share an insight, caveat, or question.
Radkiewicz et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: